Hans Wildiers setting the scene on emerging treatments, ET resistance and redefining HER2-status.

Watch our webinar on the management of HR+ HER2- metastatic #BreastCancer ➡️ register for free atWith @E_de_Azambuja @EtienneB66 Cristina Saura Manich and Valentina Guarneri 
@OncoAlert